Literature DB >> 24073730

Percutaneous radiofrequency ablation for liver metastases in breast cancer patients.

Ha Yeon Lee1, Heung Kyu Ko, Sun Hye Kim, Keun Seok Lee, Jungsil Ro, In Hae Park.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24073730     DOI： 10.1111/tbj.12170

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  3 in total

1.  Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters.

Authors:  Mitra Tewes; Michael Wilhelm Peis; Simon Bogner; Jens M Theysohn; Marcus Paul Reinboldt; Martin Schuler; Anja Welt
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-23       Impact factor: 4.553

2.  Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.

Authors:  Antonio Facciorusso; Valentina Del Prete; Nicola Crucinio; Gaetano Serviddio; Gianluigi Vendemiale; Nicola Muscatiello
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

3.  Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis.

Authors:  Yi-Bin Xiao; Bo Zhang; Yu-Lian Wu
Journal:  J Zhejiang Univ Sci B       Date:  2018-11       Impact factor: 3.066
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.